Muhammad Musa Khan | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Muhammad Musa Khan | Drug Safety and Risk Management | Best Researcher Award

Hainan Intitute of Zhejiang University | China

Assoc. Prof. Dr. Muhammad Musa Khan is an accomplished entomologist and agricultural researcher whose scientific endeavors bridge environmental toxicology, pest management, and agroecological sustainability. His academic journey reflects a strong foundation in agricultural entomology, leading to advanced expertise in pest control and ecotoxicology. Currently serving as an Associate Researcher at the Hainan Institute of Zhejiang University in China, Dr. Khan plays a leading role in investigating pesticide toxicity, insecticide resistance, and the ecological risks associated with chemical pest management in rice agroecosystems. His leadership and research contributions under the guidance of distinguished scientists have advanced global understanding of integrated pest management strategies and sustainable agricultural practices.Dr. Khan’s research experience extends to his postdoctoral work at South China Agricultural University, where he explored the management of whiteflies and diamondback moths through ultraviolet light exposure, revealing insights into immunity suppression and its implications for biological control agents. His earlier doctoral research at Huazhong Agricultural University focused on assessing the ecological risks of modern insecticides such as emamectin benzoate and chlorantraniliprole on beneficial predators like Paederus fuscipes, a natural enemy of the brown planthopper. He also evaluated the “push and pull” pest management approach using essential oils and synthetic chemicals, blending ecological knowledge with innovative pest control methods. His master’s and undergraduate studies laid the foundation for his deep understanding of insect–plant interactions, particularly in cotton crops where he analyzed morphological and biochemical traits contributing to pest resistance.A versatile and skilled experimental researcher, Dr. Khan possesses extensive expertise in molecular and biochemical methodologies. His technical proficiency includes DNA and RNA extraction, PCR, RT-qPCR, gene cloning, enzyme activity analysis, and protein profiling through SDS-PAGE and Western blotting. Additionally, his software expertise spans advanced data analysis and visualization platforms such as R-Studio, SPSS, SigmaPlot, and MEGA-X, along with strong skills in scientific illustration using BioRender and AI-based tools for bioinformatics. This blend of laboratory precision and digital innovation positions him as a modern scientist capable of integrating complex datasets into actionable scientific insights.

Profile: Google Scholar

Featured Publications

Siddiqui, J. A., Khan, M. M., Bamisile, B. S., Hafeez, M., Qasim, M., & Rasheed, M. T., et al. (2022). Role of insect gut microbiota in pesticide degradation: A review. Frontiers in Microbiology.

Hafeez, M., Ullah, F., Khan, M. M., Li, X., Zhang, Z., Shah, S., Imran, M., Assiri, M. A., et al. (2022). Metabolic-based insecticide resistance mechanism and ecofriendly approaches for controlling of beet armyworm Spodoptera exigua: A review. Environmental Science and Pollution Research.

Siddiqui, J. A., Bamisile, B. S., Khan, M. M., Islam, W., Hafeez, M., Bodlah, I., & Xu, Y. (2021). Impact of invasive ant species on native fauna across similar habitats under global environmental changes. Environmental Science and Pollution Research.

Khan, M. M., Nawaz, M., Hua, H., Cai, W., & Zhao, J. (2018). Lethal and sublethal effects of emamectin benzoate on the rove beetle Paederus fuscipes, a non-target predator of rice brown planthopper Nilaparvata lugens. Ecotoxicology and Environmental Safety.

Liu, S., Zhao, J., Hamada, C., Cai, W., Khan, M., Zou, Y., & Hua, H. (2019). Identification of attractants from plant essential oils for Cyrtorhinus lividipennis, an important predator of rice planthoppers. Journal of Pest Science.

Elli Anna Kotsailidi | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Assist. Prof. Dr. Elli Anna Kotsailidi | Clinical Trials | Best Researcher Award

University of Rochester | United States

Assist. Prof. Dr. Elli Anna Kotsailidi is a distinguished academic and clinician specializing in periodontology, implant dentistry, and health professions education. She serves as an Assistant Professor of Clinical Dentistry at the University of Rochester, School of Medicine and Dentistry, and is a key faculty member at the Eastman Institute for Oral Health. With a strong foundation in dental surgery and advanced expertise in periodontal and implant sciences, she has built a remarkable career combining clinical excellence, academic leadership, and educational innovation.Dr. Kotsailidi’s academic journey began with her dental degree from the National and Kapodistrian University of Athens, where she demonstrated early dedication to clinical precision and scientific inquiry. Her pursuit of advanced specialization led her to the Eastman Institute for Oral Health at the University of Rochester, where she completed rigorous training in periodontology and implant dentistry, refining her skills in evidence-based patient care and complex surgical procedures. Further expanding her professional vision, she completed a master’s degree in Health Professions Education at the Warner School of Education, University of Rochester, focusing on curriculum development, equitable teaching, and the enhancement of academic excellence in dental education.Her professional career reflects an unwavering commitment to both patient-centered care and academic mentorship. As Program Director and former Clinic Director in the Department of Periodontology at the Eastman Institute for Oral Health, she has played a pivotal role in shaping clinical programs, overseeing resident training, and ensuring adherence to the highest standards of quality assurance and ethical practice. Her role integrates patient management, surgical supervision, curriculum coordination, and leadership in interdisciplinary dental education involving periodontics, prosthodontics, and general dentistry.Dr. Kotsailidi’s teaching philosophy is deeply rooted in inclusivity, collaboration, and innovation. She has co-directed and taught numerous courses, including Cell Biology of Disease, Introduction to Periodontology, Oral Implantology, ABP Mock Boards, and the Literature Review Series in Periodontics and Dental Implantology. Her approach emphasizes integrative learning, clinical reasoning, and the practical application of scientific knowledge in patient care. She is also an active mentor, serving on research committees for master’s students, guiding systematic reviews and meta-analyses that contribute to evidence-based dentistry and global oral health advancement.

Profile: Orcid

Featured Publications

Umbrio, L. R. N., Pham, H. M., Barmak, A. B., Assery, N., & Kotsailidi, E. A. (2025). Association between selective serotonin reuptake inhibitors and the periodontal status: A systematic review and meta-analysis of observational clinical studies. Evidence-Based Dentistry.

Benzaquen, S. I., Torabi Ardakani, M., Tsigarida, A., Ercoli, C., Barmak, B., Chochlidakis, K. M., & Kotsailidi, E. A. (2025). Biologic complications with removable partial dentures assisted by short implants: A 34-month pilot randomized controlled clinical trial. The Journal of Prosthetic Dentistry.

Kotsailidi, E. A., Johnson, L., Burns, C., Rossouw, P. E., & Michelogiannakis, D. (2025). Surgically facilitated orthodontics with clear aligners for severe malocclusion and gingival recessions. Clinical Advances in Periodontics.

Burns, C., Kotsailidi, E. A., Alshuraim, F., Dadjoo, S., Tzouma, K., Pedrinaci, I., Rossouw, P. E., & Michelogiannakis, D. (2024). Interdisciplinary orthodontic treatment with digitally-guided autotransplantation in a patient with a missing permanent maxillary left lateral incisor and a supernumerary mandibular incisor. AJO-DO Clinical Companion.

Basant Farag | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Basant Farag | Drug Discovery and Development | Best Researcher Award

Zagazig University Faculty of Science | Egypt

Dr. Basant Farag is a distinguished organic chemist and assistant lecturer at the Department of Chemistry, Faculty of Science, Zagazig University, Egypt, with extensive expertise in the synthesis, biological evaluation, and computational studies of heterocyclic compounds. She completed her Ph.D. in Organic Chemistry at Zagazig University, building on her M.Sc. and B.Sc. degrees in the same field, demonstrating a consistent commitment to advancing chemical sciences. Her academic career encompasses teaching, mentoring students, and conducting cutting-edge research while serving as a teaching assistant and assistant lecturer, preparing lectures, evaluating students, and engaging in independent research projects. Dr. Farag is also an accomplished international reviewer for numerous journals including Chemistry Select, Eurasian Journal of Chemistry, Journal of Molecular Structure, Bioorganic Chemistry, and International Journal of Biological Macromolecules, highlighting her broad expertise and recognition in the global scientific community.Her research portfolio includes pioneering studies in the design and synthesis of biologically active heterocyclic compounds, focusing on pharmacologically relevant molecules with anticancer, antimicrobial, and antitubercular properties. Her notable publications include Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase, Mechanochemical Synthesis and Molecular Docking Studies of New Azines Bearing Indole as Anticancer Agents, Green Synthesis and Molecular Docking Study of Some New Thiazoles Using Terephthalohydrazide Chitosan Hydrogel as Ecofriendly Biopolymeric Catalyst, Green Route Synthesis and Molecular Docking of Azines Using Cellulose Sulfuric Acid under Microwave Irradiation, Synthesis, Molecular Docking and Anticancer Activity of Some 5-Aryl-5,10-Dihydropyrido[2,3-d:6,5-d′]Dipyrimidine-2,4,6,8-Tetraone Derivatives and Pyrido[2,3-d], Synthesis, Molecular Docking Study, and Biological Evaluation of New Thiadiazole and Thiazole Derivatives Incorporating Isoindoline-1,3-Dione Moiety as Anticancer and Antimicrobial Agents, Green Biocatalyst for Ultrasound-Assisted Thiazole Derivatives: Synthesis, Antibacterial Evaluation, and Docking Analysis, Cyanauric Chloride as a Key Precursor and a Core Component for Three-Armed Triazolopyrimidines: Recent Finding About SARs and Docking Analyses, Chitosan–Sulfonic Acid-Catalyzed Green Synthesis of Naphthalene-Based Azines as Potential Anticancer Agents, Synthesis, Molecular Docking, In Silico Study, and Evaluation of Bis-Thiazole-Based Curcumin Derivatives as Potential Antimicrobial Agents, and Design and Synthesis of Novel Hybrids Incorporating Thiadiazole or Thiazole-Naphthalene: Anticancer Assessment and Molecular Docking Study.

Profile: Google Scholar

Featured Publications

Abolibda, T. Z., Fathalla, M., Farag, B., Zaki, M. E. A., & Gomha, S. M. (n.d.). Synthesis and molecular docking of some novel 3-thiazolyl-coumarins as inhibitors of VEGFR-2 kinase. Molecules.

Ibrahim, M. S., Farag, B., Al-Humaidi, J. Y., Zaki, M. E. A., Fathalla, M., & Gomha, S. M. (n.d.). Mechanochemical synthesis and molecular docking studies of new azines bearing indole as anticancer agents. Molecules.

Gomha, S. M., Riyadh, S. M., Alharbi, R. A. K., Zaki, M. E. A., Abolibda, T. Z., & Farag, B. (n.d.). Green route synthesis and molecular docking of azines using cellulose sulfuric acid under microwave irradiation. Crystals.

Al-Humaidi, J. Y., Gomha, S. M., El-Ghany, N. A. A., Farag, B., Zaki, M. E. A., et al. (n.d.). Green synthesis and molecular docking study of some new thiazoles using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst. Catalysts.

Hussein, A. M., Gomha, S. M., El-Ghany, N. A. A., Zaki, M. E. A., Farag, B., et al. (n.d.). Green biocatalyst for ultrasound-assisted thiazole derivatives: Synthesis, antibacterial evaluation, and docking analysis. ACS Omega.

Mokbel, W. A., Hosny, M. A., Gomha, S. M., Zaki, M. E. A., Farag, B., El Farargy, A. F., et al. (n.d.). Synthesis, molecular docking study, and biological evaluation of new thiadiazole and thiazole derivatives incorporating isoindoline-1,3-dione moiety as anticancer and antimicrobial agents. Results in Chemistry.

Hui Li | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hui Li | Drug Delivery Systems | Best Researcher Award

Woosuk University | South Korea

Dr. Hui Li is a distinguished medical scientist and otolaryngologist whose work bridges clinical medicine, translational research, and pharmaceutical innovation. He earned his Ph.D. in Translational Medicine from Seoul National University College of Medicine in Korea, where his research focused on the molecular mechanisms underlying hearing loss and radiation-induced cellular changes. Prior to his doctoral training, he completed both his Master’s and Bachelor’s degrees in Clinical Medicine from Yanbian University of Medicine in China, establishing a strong foundation in clinical diagnostics, therapeutic approaches, and patient-centered medical care.Dr. Li’s professional journey reflects an impressive progression from clinical expertise to cutting-edge biomedical research. He began his career as a medical doctor and otolaryngologist at Yanbian Yongjeong National Hospital, where he honed his clinical acumen in diagnosing and treating ear, nose, and throat disorders. His clinical excellence led him to serve as a resident and research fellow in the Department of Otolaryngology at the Affiliated Hospital of Yanbian University of Medicine, where he began integrating research into his clinical practice. He later worked as a specialist at the Yanbian National Ophthalmology & Otolaryngology Hospital, focusing on complex cases of auditory and vestibular dysfunction. These formative years in medical practice equipped him with invaluable clinical insight that continues to inform his research in translational medicine and pharmacotherapeutics.Dr. Li transitioned into academic research with his appointment as a doctoral researcher at the Department of Translational Medicine (Otolaryngology) at Seoul National University College of Medicine. There, he conducted pivotal studies on novel therapeutic delivery systems, inner ear protection mechanisms, and the molecular pathways involved in hearing impairment. His research excellence earned him postdoctoral appointments at the Cancer Research Institute within the same university, where he explored immune-modulatory effects of radiotherapy and the potential of macrophage polarization in mitigating cancer progression. Currently, he serves as a Postdoctoral Research Fellow at the Laboratory of Biopharmaceutics, Industry-Academia Cooperation Foundation, Woosuk University, Korea, where he investigates advanced drug formulations, biopharmaceutical delivery mechanisms, and the translational potential of controlled-release therapeutics.

Profile: Scopus

Featured Publications

Li, J., Wang, H., Zhang, Y., & Chen, L. (2022). Comprehensive intervention and effect of martial arts routines on children with autism. Journal of Environmental and Public Health, 2022.

Turnwait Michael | Regulatory Affairs | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Turnwait Michael | Regulatory Affairs | Best Researcher Award

University of Johannesburg | South Africa

Dr. Turnwait Michael is a distinguished social scientist and public health researcher whose work bridges sociology, demography, and epidemiology to address some of the most pressing health challenges across Africa. He holds a Ph.D. in Sociology with a specialization in Medical Demography from the University of Ibadan, Nigeria, an MPH in Epidemiology and Medical Statistics from the College of Medicine, University of Ibadan, an MSc in Sociology/Demography, and a BSc in Sociology from Niger Delta University. His robust academic foundation is further strengthened by specialized certifications and global training in family planning, public health nutrition, implementation research, antimicrobial resistance, and project management from international institutions in the USA, Canada, Malaysia, and Nigeria.Dr. Michael currently serves as a Postdoctoral Research Fellow at the University of Johannesburg, South Africa, where he conducts advanced research on social determinants of health, reproductive and adolescent health, gender norms, and health systems strengthening. His postdoctoral work extends to collaborative projects supported by competitive international grants such as the EU Intra-Africa Mobility Grant and the University Capacity Development Programme (UCDP) Grant. In this role, he also mentors postgraduate students, contributes to academic publications, and engages in interdisciplinary fundraising efforts for health research and policy innovation.Before joining the University of Johannesburg, Dr. Michael served as Lecturer II in Medical Sociology and Demography at Hallmark University, Nigeria, where he taught and supervised undergraduate and postgraduate research on applied demography, health sociology, social statistics, and research methods. He has also contributed to national policy through his role as a Technical Analyst with the Presidential Health Sector Committee in Nigeria, where he worked on health policy memoranda, pharmaceutical regulations, and universal health coverage frameworks. His consultancy experience with the development Research and Projects Centre (dRPC) spans reproductive rights, gender-based violence, climate change, child marriage, migration, and digital education initiatives.

Profile: Google Scholar

Featured Publications

Michael, T. O., & Odeyemi, M. A. (2017). Nigeria’s population policies: Issues, challenges and prospects. Ibadan Journal of the Social Sciences.

Michael, T. O., Ojo, T. F., Ijabadeniyi, O. A., Ibikunle, M. A., Oni, J. O., & Agboola, A. A. (2024). Prevalence and factors associated with contraceptive use among sexually active adolescent girls in 25 sub-Saharan African countries. PLOS ONE..

Michael, T. O., Agbana, R. D., Ojo, T. F., Kukoyi, O. B., Ekpenyong, A. S., & Ukwandu, D. (2021). COVID-19 pandemic and unmet need for family planning in Nigeria. Pan African Medical Journal.

Agbana, R. D., Michael, T. O., & Ojo, T. F. (2023). Family planning method discontinuation among Nigerian women: Evidence from the Nigeria Demographic and Health Survey 2018. Journal of Taibah University Medical Sciences.

Michael, T. O., Nwokocha, E. E., & Agbana, R. D. (2023). Issues in antenwatal care services utilization among unmarried adolescents in Akwa Ibom State, Nigeria. Journal of Population and Social Studies.

Michael, T. O., & Scent, G. A. T. (2017). Correlates of contraceptive use and the desire for fewer children in Nigeria. The Nigerian Journal of Sociology and Anthropology.

Ekpenyong, A. S., & Turnwait, M. O. (2016). Social media and sexual reproductive health behaviour among adolescents in Bayelsa State, Nigeria. American International Journal of Research in Humanities, Arts and Social Sciences.

Amirhosein Kefayat | Pharmaceutical Chemistry | Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Dr. Amirhosein Kefayat | Pharmaceutical Chemistry | Top Pharmaceutical Scientist Award

Edinburgh of University | United Kingdom

Dr. Amirhosein Kefayat is a distinguished physician-scientist specializing in oncology, nanomedicine, cancer immunotherapy, and radiation oncology, with extensive experience in translational research and clinical studies. He earned his Doctorate of Medicine (MD) from Isfahan University of Medical Sciences in 2019 and has since advanced his qualifications with multiple prestigious certifications, including full registration with the General Medical Council (UK) and ongoing ECFMG certification for the United States.Currently serving as a Clinical Research Fellow at the Institute of Genetics & Cancer, University of Edinburgh & NHS Lothian (UK), Dr. Kefayat contributes to UK-wide clinical trials such as ACESO, BIOPIC, DEFINE, PROFILE, PAN-IBD, and Gut Cell Atlas. He also leads systematic review and meta-analysis teams, influencing major clinical guidelines like the British Society of Gastroenterology 2024 update.Previously, as a Clinical Research Fellow at the Dept. of Radiotherapy & Oncology, Arak University of Medical Sciences (Iran), he led multiple high-impact research projects, resulting in numerous publications, international conference presentations, patents, and national research grants (INSF, NIMAD).Dr. Kefayat has published extensively in top Q1 journals such as Carbohydrate Polymers, Biosensors & Bioelectronics, Vaccine, Scientific Reports, Journal of Biomolecular Structure & Dynamics, and Nanomedicine. His work on novel cancer vaccines, wound healing biomaterials, and radiosensitizers ranks among the top 1–10% most-cited papers worldwide, reflecting his global research impact.His notable accolades include recognition as the top 0.5% of scholars worldwide (2024), membership in Iran’s National Elites Foundation, and multiple national research grants. His patented biomaterial for diabetic wound healing demonstrates his commitment to bridging laboratory research with clinical application.

Profile: Google Scholar

Featured Publications

Eskandarinia, A., Kefayat, A., Agheb, M., Rafienia, M., & Amini Baghbadorani, M. (2020). A novel bilayer wound dressing composed of a dense polyurethane/propolis membrane and a biodegradable polycaprolactone/gelatin nanofibrous scaffold. Scientific Reports, 10(1), 3063.

Eskandarinia, A., Kefayat, A., Gharakhloo, M., Agheb, M., Khodabakhshi, D., Rafienia, M., & Navid, S. (2020). A propolis enriched polyurethane-hyaluronic acid nanofibrous wound dressing with remarkable antibacterial and wound healing activities. International Journal of Biological Macromolecules, 149, 467–476.

Safavi, A., Kefayat, A., Mahdevar, E., Abiri, A., & Ghahremani, F. (2020). Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine, 38(48), 7612–7628.

Khodabakhshi, D., Eskandarinia, A., Kefayat, A., Rafienia, M., Navid, S., & Agheb, M. (2019). In vitro and in vivo performance of a propolis-coated polyurethane wound dressing with high porosity and antibacterial efficacy. Colloids and Surfaces B: Biointerfaces, 178, 177–184.

Eskandarinia, A., Kefayat, A., Rafienia, M., Agheb, M., Navid, S., & Ebrahimpour, K. (2019). Cornstarch-based wound dressing incorporated with hyaluronic acid and propolis: In vitro and in vivo studies. Carbohydrate Polymers, 216, 25–35.

Karizmeh, M. S., Poursamar, S. A., Kefayat, A., Farahbakhsh, Z., & Rafienia, M. (2022). An in vitro and in vivo study of PCL/chitosan electrospun mat on polyurethane/propolis foam as a bilayer wound dressing. Biomaterials Advances, 135, 112667.

Ghahremani, F., Shahbazi-Gahrouei, D., Kefayat, A., Motaghi, H., & Amouheidari, A. (2018). AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells. RSC Advances, 8(8), 4249–4258.

Safavi, A., Kefayat, A., Abiri, A., Mahdevar, E., Behnia, A. H., & Ghahremani, F. (2019). In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma. Molecular Immunology, 112, 93–102.

Krishna Pada Das | Bioinformatics in Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Krishna Pada Das | Bioinformatics in Pharmaceuticals | Best Researcher Award

Mahadevananda Mahavidyalaya | India

Assoc. Prof. Dr. Krishna Pada Das is a distinguished academic with a robust background in mathematical biology, particularly in the field of population dynamics and mathematical modeling. He obtained his Bachelor’s and Master’s degrees in Mathematical Science from Calcutta University, Kolkata, before completing his Ph.D. in Applied Mathematics at Jadavpur University, Kolkata, under the guidance of Prof. Joydev Chattopadhyay of the Indian Statistical Institute. His doctoral research, which focused on the nonlinear dynamics of predator-prey interactions with disease in the population, laid the foundation for his continued work in mathematical modeling of ecological and epidemiological systems.Dr. Das has held various academic positions throughout his career, starting as a Junior Research Fellow at the Indian Statistical Institute in the Agricultural and Ecological Research Unit, where he worked from 2006 to 2008. He was later promoted to Senior Research Fellow until 2010. His academic career at Mahadevananda Mahavidyalaya, Kolkata, began in 2010, where he served as an Assistant Professor and was later promoted to Associate Professor in 2022. His academic positions have allowed him to make significant contributions to both research and teaching in the field of applied mathematics, especially in mathematical ecology and epidemiology.His primary research interests lie in mathematical modeling for biological systems, with a particular focus on the dynamics of populations in ecological and epidemiological settings. His work spans a variety of complex systems, including predator-prey models, disease transmission dynamics, plankton population dynamics, and eco-epidemiology. Dr. Das uses advanced mathematical techniques, including ordinary differential equations, stochastic processes, delay differential equations, and fractional calculus, to model the behavior of these systems. His current research explores HIV infection models, epidemiological models, and eco-epidemiological systems, with an emphasis on understanding the effects of factors such as time delays, diffusion, spatio-temporal dynamics, and the role of randomness in these systems.

Profile: Google Scholar

Featured Publications

Das, K., & Mukherjee, A. K. (2007). Differential utilization of pyrene as the sole source of carbon by Bacillus subtilis and Pseudomonas aeruginosa strains: Role of biosurfactants in enhancing. Journal of Applied Microbiology, 102(1), 195-203.

Soni, B. K., Das, K., & Ghose, T. K. (1982). Bioconversion of agro-wastes into acetone butanol. Biotechnology Letters, 4(1), 19-22.

Dutta, S. K., Das, K., Ghosh, B., & Blackman, C. F. (1992). Dose dependence of acetylcholinesterase activity in neuroblastoma cells exposed to modulated radio-frequency electromagnetic radiation. Bioelectromagnetics, 13(4), 317-322.

Kooi, B. W., van Voorn, G. A. K., & Das, K. P. (2011). Stabilization and complex dynamics in a predator–prey model with predator suffering from an infectious disease. Ecological Complexity, 8(1), 113-122.

Das, C. R., Mondal, N. K., Aditya, P., Datta, J. K., Banerjee, A., & Das, K. (2012). Allelopathic potentialities of leachates of leaf litter of some selected tree species on gram seeds under laboratory conditions. Asian Journal of Experimental Biological Sciences, 3(1), 59-65.

Das, K. P., Kundu, K., & Chattopadhyay, J. (2011). A predator–prey mathematical model with both the populations affected by diseases. Ecological Complexity, 8(1), 68-80.

Ghose, T. K., & Das, K. (2006). A simplified kinetic approach to cellulose-cellulase system. Advances in Biochemical Engineering, 1, 55-76.

Das, A., Ghosh, S., Das, K., Basu, T., Das, M., & Dutta, I. (2020). Modeling the effect of area deprivation on COVID-19 incidences: A study of Chennai megacity, India. Public Health, 185, 266-269.

Shadi Hamoud | Clinical Trials | Excellence in Research Award

Published on by Top Pharmaceutical

Dr. Shadi Hamoud | Clinical Trials | Excellence in Research Award

Rambam health care campus | Israel

Dr. Shadi Hamoud is a distinguished physician, clinical researcher, and academic leader whose career spans internal medicine, cardiovascular research, and translational medicine. Earning his medical degree with honors from the Faculty of Medicine at the Hebrew University in Jerusalem, Dr. Hamoud embarked on a professional journey characterized by clinical excellence, research innovation, and a deep commitment to medical education. Over the years, he has combined patient-centered care with groundbreaking research, focusing on lipoprotein oxidation, atherosclerosis, the role of the enzyme heparanase in kidney injury, fatty liver disease, and cardiovascular disorders, as well as pioneering clinical trials for novel oral anticoagulants, lipid-modifying agents, diabetes treatments, and therapies for emerging infectious diseases such as COVID-19.As Deputy Director of the Department of Internal Medicine E at Rambam Medical Center and Director of the Clinical Research Unit, Dr. Hamoud has overseen numerous national and international clinical studies, collaborating with leading pharmaceutical companies, including Bayer, Pfizer, Novartis, Sanofi, and AstraZeneca. His research portfolio reflects expertise in designing and conducting complex multicenter clinical trials addressing some of the most challenging issues in cardiovascular medicine and metabolic diseases. Additionally, his clinical consultancy roles across multiple departments at Rambam Health Care Campus highlight his interdisciplinary approach to medicine, ensuring that research findings translate effectively into improved patient outcomes.An accomplished educator, Dr. Hamoud has dedicated decades to training the next generation of physicians, serving as a clinical lecturer at the Technion-Israel Institute of Technology and mentoring medical students, interns, and graduate researchers. Under his supervision, numerous MD and basic science theses have been completed, exploring critical areas such as oxidative stress, endothelial dysfunction, liver steatosis, and the molecular pathways of atherosclerosis. His leadership as Program Director for the Internal Medicine Preparatory Course for National Licensing Examinations further reflects his commitment to academic excellence and medical training standards.

Profile: Orcid

Featured Publications

Hamoud, S., Hacker, I., Karram, T., Fokra, A., Kabala, A., & Abassi, Z. (2024). Gender-specific renoprotective pathways in αMUPA transgenic mice subjected to acute kidney injury. International Journal of Molecular Sciences.

Cohen-Segev, R., Nativ, O., Kinaneh, S., Aronson, D., Kabala, A., Hamoud, S., Karram, T., & Abassi, Z. (2023). Effects of angiotensin 1-7 and Mas receptor agonist on renal system in a rat model of heart failure. International Journal of Molecular Sciences.

Kinaneh, S., Hijaze, W., Mansour-Wattad, L., Hammoud, R., Zaidani, H., Kabala, A., & Hamoud, S. (2022). Heparanase inhibition prevents liver steatosis in E₀ mice. Journal of Clinical Medicine.

[Author names not fully provided]. (n.d.). Predictors of survival in subjects treated in the “shock room” of the emergency department in a tertiary medical center.

Xiangxuan Zhao | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Xiangxuan Zhao | Drug Discovery and Development | Best Researcher Award

Liaoning University of Traditional Chinese Medicine | China

Prof. Xiangxuan Zhao is a distinguished cell biologist and an eminent academic leader renowned for his pioneering contributions to the field of natural medicine-derived anti-cancer therapeutics. Serving as Professor, Doctoral Supervisor, and Postdoctoral Mentor, he holds prestigious positions as the Dean of the College of Laboratory Animal Medicine and Director of the Laboratory Animal Center at the Liaoning University of Traditional Chinese Medicine in Shenyang, China. With a career dedicated to advancing the frontiers of cancer biology and pharmaceutical innovation, Prof. Zhao has established himself as a leading authority in tumor drug resistance mechanisms, molecular target discovery, molecular targeted drug development, and tumor immunotherapy research.Prof. Zhao’s academic journey reflects a blend of scientific rigor and innovative leadership. Prior to his current roles, he contributed significantly as Deputy Director of the Engineering Technology Center for TCM Innovation at Liaoning University of Traditional Chinese Medicine and as a Researcher at the Health Science Research Institute of China Medical University. His earlier tenure as an Associate Researcher at Shengjing Hospital, China Medical University, laid the groundwork for his expertise in translational medicine, fostering a seamless bridge between laboratory research and clinical applications.A prolific scholar, Prof. Zhao has authored and co-authored eighty-four academic papers, including thirty-one SCI-indexed publications with a cumulative impact factor of one hundred eighty-eight. Among these, five papers boast impact factors exceeding ten, with his highest-impact publication reaching an impressive twenty-seven point four. His scientific excellence is further reflected in the thirteen national patents he holds, with four as the first inventor, underscoring his role as a trailblazer in molecular oncology and therapeutic innovation.

Profile: Orcid

Featured Publications

Liu, Y., Guo, R., Xue, C., Zhang, X., Xiao, F., Zhao, X., Zhu, Z., & Li, K. (2025). Phytosphingosine suppresses gastric cancer through SFRP4/β-catenin axis-mediated Wnt signaling pathway inhibition. Chemico-Biological Interactions.

Ke, W., Wang, H., Zhao, X., & Lu, Z. (2021). Foeniculum vulgare seed extract exerts anti-cancer effects on hepatocellular carcinoma. Food & Function.

Sun, W., Ren, Y., Lu, Z., & Zhao, X. (2020). The potential roles of exosomes in pancreatic cancer initiation and metastasis. Molecular Cancer.

Ke, W., Zhao, X., & Lu, Z. (2020). Bcl-2 is essential for Foeniculum vulgare seed extract-induced apoptosis in lung cancer. Research Square.

Huachuan Zheng | Pharmacology | Best Innovation Award

Published on by Top Pharmaceutical

Prof. Dr. Huachuan Zheng | Pharmacology | Best Innovation Award

The First Affiliated Hospital of Jinzhou Medical University | China

Prof. Dr. Huachuan Zheng is a distinguished scholar, educator, and research leader whose pioneering work in oncology has significantly advanced the understanding of cancer biology and its clinical applications. With a strong academic foundation that began at China Medical University, where he earned his B.M., M.S., and M.D. degrees, followed by a Ph.D. in Pathology from the University of Toyama in Japan, Prof. Zheng has built a career dedicated to unraveling the molecular mechanisms underlying tumor development and progression. His postdoctoral fellowship at the Kanagawa Cancer Center in Japan further strengthened his expertise in cancer molecular pathology, setting the stage for a prolific academic and research journey.Throughout his career, Prof. Zheng has held several prestigious positions, including serving as the Director of Basic and Translational Cancer Laboratories, Central Laboratories, Experimental Animal Centers, and Cancer Experiment Centers at leading institutions such as the First Affiliated Hospital of Jinzhou Medical University and the Affiliated Hospital of Chengde Medical University. His leadership has extended beyond research to academic administration, where he has contributed as Secretary of the Party Committee and Executive Vice Dean at the Jinzhou Medical University Academy of Life Sciences. Currently, he serves as Director, Professor, and Doctoral Supervisor at the First Affiliated Hospital of Jinzhou Medical University, where he continues to guide innovative cancer research and mentor the next generation of scientists. Prof. Zheng’s research has focused on critical areas such as the molecular mechanisms driving malignant tumor initiation and metastasis, the carcinogenic pathways involving JC virus T antigen, cancer bioinformatics, and the development of spontaneous tumor transgenic animal models. Prof. Zheng leads cutting-edge research on malignant tumor initiation, metastasis, JC virus oncogenesis, cancer bioinformatics, and transgenic animal models. His prolific output includes 212 documents, 5,182 citations, and an h-index of 36, reflecting his global impact on cancer research and precision oncology. His groundbreaking work has not only contributed to the fundamental understanding of cancer biology but has also paved the way for translational applications in early diagnosis, targeted therapy, and personalized treatment approaches for various malignancies, including lung, digestive system, and gynecological cancers.

Profile: Scopus

Featured Publications

Author(s). (2025). RNF180 suppressed aggressiveness by degrading NOTCH1, TRIM24 and FOXC1, and chemoresistance by degrading ACC1 and ACLY in colorectal cancer. International Immunopharmacology.

Author(s). (2025). Effective synthesis of benzodiazepine sulfonamide-based MGAT2 inhibitors and evaluation of their antitumor activity. RSC Advances.

Author(s). (2025). Dkk3 inhibits the aggressiveness and mitigates chemoresistance through low lipid droplet formation in gastric cancer: A biomarker and gene therapy target. International Immunopharmacology.

Author(s). (2025). IFN-γ downregulates miR-4319 to enhance NLRC5 and MHC-I expression in MHC-I-deficient breast cancer cells. Cancer Biology and Therapy.

Author(s). (2025). RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer. Frontiers in Pharmacology.

Author(s). (2025). Chaetoglobosin A induces apoptosis in T-24 human bladder cancer cells through oxidative stress and MAPK/PI3K-AKTmTOR pathway. PeerJ.

Author(s). (2024). The promoting effects of Grin2d expression in tumorigenesis and the aggressiveness of esophageal cancer. Histology and Histopathology.

Author(s). (2024). The antitumor and sorafenib-resistant reversal effects of ursolic acid on hepatocellular carcinoma via targeting ING5. International Journal of Biological Sciences.

Author(s). (2024). The oncogenic roles of GPR176 in ovarian cancer: A molecular target for aggressiveness and gene therapy. Journal of Obstetrics and Gynaecology.